Apyx Medical
APYX
74 hedge funds and large institutions have $261M invested in Apyx Medical in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
35% more capital invested
Capital invested by funds: $194M → $261M (+$67.3M)
3% more funds holding
Funds holding: 72 → 74 (+2)
0.16% more ownership
Funds ownership: 54.85% → 55.02% (+0.16%)
14% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$3.43M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$1.35M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$649K |
| 4 |
GCA
Greenwood Capital Associates
Greenwood,
South Carolina
|
+$577K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$568K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$2.22M |
| 2 |
Millennium Management
New York
|
-$1.05M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$1,000K |
| 4 |
JP Morgan Chase
New York
|
-$605K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$500K |
APYX Hedge Fund Activity: Q3 2021 in Review
74 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2021, worth a combined $261M — up 35% from $194M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new APYX positions and 7 closed out — a net gain of 3 holders — while 25 added to existing stakes and 29 trimmed.
The largest buyer was Cowen and Company, adding an estimated $3.43M. The largest seller was Archon Capital Management, cutting an estimated $2.22M.
- 74 institutional investors held Apyx Medical (APYX) as of Q3 2021, up from 72 in Q2 2021.
- Funds reported $261M of Apyx Medical stock for Q3 2021, up 35% quarter-over-quarter.
- 10 funds opened new Apyx Medical positions in Q3 2021 and 7 closed out, a net change of +3 holders.
- The largest Apyx Medical buyer in Q3 2021 was Cowen and Company, an estimated $3.43M added.
- The largest Apyx Medical seller in Q3 2021 was Archon Capital Management, an estimated $2.22M sold.
Based on aggregated 13F filings for Q3 2021.